Breast cancer HER2 analysis by extra-short incubation microfluidics-assisted fluorescence in situ hybridization (ESIMA FISH)
- 1 April 2018
- journal article
- research article
- Published by Elsevier in Microelectronic Engineering
- Vol. 189, 33-38
Abstract
No abstract availableKeywords
Funding Information
- European Union Ideas (ERC-2012-AdG-320404)
This publication has 18 references indexed in Scilit:
- Microfluidic processor allows rapid HER2 immunohistochemistry of breast carcinomas and significantly reduces ambiguous (2+) read-outsProceedings of the National Academy of Sciences, 2013
- Fast and Non-Toxic In Situ Hybridization without Blocking of Repetitive SequencesPLOS ONE, 2012
- Same‐day prenatal diagnosis of common chromosomal aneuploidies using microfluidics‐fluorescence in situ hybridizationPrenatal Diagnosis, 2012
- HistoFlex—a microfluidic device providing uniform flow conditions enabling highly sensitive, reproducible and quantitative in situ hybridizationsLab on a Chip, 2011
- Choosing the right cell line for breast cancer researchBreast Cancer Research, 2011
- Microfluidic fluorescence in situ hybridization and flow cytometry (μFlowFISH)Lab on a Chip, 2011
- Metaphase FISH on a Chip: Miniaturized Microfluidic Device for Fluorescence in situ HybridizationSensors, 2010
- Miniaturized FISH for Screening of Onco-Hematological MalignanciesBioTechniques, 2010
- An integrated microfluidic chip for chromosome enumeration using fluorescence in situ hybridizationLab on a Chip, 2008
- FISH and chips: chromosomal analysis on microfluidic platformsIET Nanobiotechnology, 2007